---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-019783"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-02T23:47:14.273393+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Baxter Q1 2024: sales $3.59B (+3% CC), adj. EPS $0.65, beating guidance; FY2024 adj. EPS guidance $2.88-$2.98

## Summary
- Q1 sales $3.59B (+2% reported, +3% CC); GAAP EPS $0.07; adj. EPS $0.65, above guidance.
- FY 2024 guidance: sales growth ~2% reported, 2-3% CC; adj. EPS $2.88-$2.98.
- FDA clearance for Novum IQ large volume infusion pump and Dose IQ Safety Software.
- CEO cited solid operational execution and benefits from new operating model.

## SEC filing metadata
- accession: 0001628280-24-019783
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/0001628280-24-019783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/bax-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-019783
- JSON: https://secwatch.observer/filing/0001628280-24-019783.json
- Plain text: https://secwatch.observer/filing/0001628280-24-019783.txt

## Key facts
- Earnings Releases
  BAXTER INTERNATIONAL INC updated its first quarter 2024 guidance (raised).
  - Period: first quarter 2024
  - Guidance: raised
  - Result: reported results
  source text: On May 2, 2024, Baxter International Inc. (the Company) issued an earnings press release for the period ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828024019783/0001628280-24-019783-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.